Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

PURPOSE: We conducted a post hoc analysis of the vandetanib phase III trial involving patients with advanced medullary thyroid cancer (MTC) to assess the efficacy and safety of vandetanib in patients with progressive and symptomatic MTC. The primary objective of the analysis was to determine progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreissl, Michael C., Bastholt, Lars, Elisei, Rossella, Haddad, Robert, Hauch, Ole, Jarząb, Barbara, Robinson, Bruce, Colzani, Raffaella, Foster, Meredith, Weiss, Richard, Schlumberger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430220/
https://www.ncbi.nlm.nih.gov/pubmed/32584630
http://dx.doi.org/10.1200/JCO.19.02790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430220/
https://www.ncbi.nlm.nih.gov/pubmed/32584630
http://dx.doi.org/10.1200/JCO.19.02790

Ejemplares similares